HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Teng Yu Selected Research

Adenine Nucleotide Translocator 1

8/2015ABT-737 sensitizes curcumin-induced anti-melanoma cell activity through facilitating mPTP death pathway.
5/2014Curcumin-induced melanoma cell death is associated with mitochondrial permeability transition pore (mPTP) opening.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Teng Yu Research Topics

Disease

7Neoplasms (Cancer)
01/2022 - 01/2014
5Melanoma (Melanoma, Malignant)
08/2015 - 10/2010
3Infections
02/2022 - 10/2011
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 03/2014
2Lymphoma (Lymphomas)
01/2021 - 03/2014
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2021 - 07/2019
2Stomach Neoplasms (Stomach Cancer)
09/2020 - 07/2020
1Adenocarcinoma
01/2022
1Signet Ring Cell Carcinoma
01/2022
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2021
1Graft vs Host Disease (Graft-Versus-Host Disease)
07/2021
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021
1Lupus Nephritis
01/2021
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2021
1Autoimmune Diseases (Autoimmune Disease)
01/2021
1HIV Infections (HIV Infection)
01/2021
1Residual Neoplasm
01/2020
1Multiple Myeloma
07/2019
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017
1Lung Neoplasms (Lung Cancer)
01/2017
1Pseudorabies
01/2016
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2014
1Experimental Melanoma
01/2014
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2013
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2013
1Ovarian Neoplasms (Ovarian Cancer)
11/2011
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
10/2011
1Edema (Dropsy)
04/2009

Drug/Important Bio-Agent (IBA)

5CurcuminIBA
08/2015 - 10/2010
4CeramidesIBA
01/2014 - 10/2010
2Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2010
2Cyclosporine (Ciclosporin)FDA LinkGeneric
07/2021 - 08/2015
2Histones (Histone)IBA
01/2021 - 10/2010
2VaccinesIBA
01/2016 - 04/2009
2Cyclophilins (Cyclophilin)IBA
08/2015 - 05/2014
2Adenine Nucleotide Translocator 1IBA
08/2015 - 05/2014
2Mitochondrial Permeability Transition PoreIBA
08/2015 - 05/2014
21- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
08/2015 - 05/2014
2Phosphotransferases (Kinase)IBA
11/2013 - 11/2011
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2013 - 11/2011
1Nucleic AcidsIBA
02/2022
1Biological ProductsIBA
01/2022
1APOBEC-1 DeaminaseIBA
01/2022
1Cytidine DeaminaseIBA
01/2022
1Sirolimus (Rapamycin)FDA Link
07/2021
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
07/2021
1InterleukinsIBA
01/2021
1AntibodiesIBA
01/2021
1Interleukin-17 (Interleukin 17)IBA
01/2021
1NeuropeptidesIBA
01/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1Calcitonin Gene-Related PeptideIBA
01/2021
1Nucleosomes (Nucleosome)IBA
01/2021
1Interleukin-23 (Interleukin 23)IBA
01/2021
1AutoantibodiesIBA
01/2021
1Carrier Proteins (Binding Protein)IBA
09/2020
1Heterotrimeric GTP-Binding Proteins (Heterotrimeric G-Proteins)IBA
09/2020
1U 0126 (UO 126)IBA
09/2020
1Guanine NucleotidesIBA
09/2020
1Fluorouracil (Carac)FDA LinkGeneric
07/2020
1Proteasome InhibitorsIBA
07/2019
1N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA
07/2019
1Bortezomib (Velcade)FDA Link
07/2019
1Histone Deacetylases (Histone Deacetylase)IBA
07/2019
1CaspasesIBA
07/2019
1Histone Deacetylase InhibitorsIBA
07/2019
1Tumor Biomarkers (Tumor Markers)IBA
01/2017
1pro-gastrin-releasing peptide (31-98)IBA
01/2017
1ABT-737IBA
08/2015
1sanglifehrin AIBA
08/2015
1Cytochromes c (Cytochrome c)IBA
05/2014
1Monoclonal AntibodiesIBA
03/2014
1Rituximab (Mabthera)FDA Link
03/2014
1Nuclear Proteins (Protein, Nuclear)IBA
03/2014
1ResveratrolIBA
01/2014
1Cysteine (L-Cysteine)FDA Link
11/2013
1Imatinib Mesylate (Gleevec)FDA Link
01/2013
1RV 538 (PDMP)IBA
02/2012
1GlycosphingolipidsIBA
02/2012
1JNK Mitogen-Activated Protein KinasesIBA
02/2012
1Mechanistic Target of Rapamycin Complex 1IBA
11/2011
1Caspase 3 (Caspase-3)IBA
11/2011
1perifosineIBA
11/2011
1AMP-Activated Protein KinasesIBA
11/2011
1Paclitaxel (Taxol)FDA LinkGeneric
11/2011
1Inosine Triphosphate (ITP)IBA
10/2011
1bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA
10/2010
1DNA (Deoxyribonucleic Acid)IBA
10/2010

Therapy/Procedure

3Drug Therapy (Chemotherapy)
07/2020 - 10/2010
1Chemoradiotherapy
07/2021
1Hematopoietic Stem Cell Transplantation
07/2021
1Male Circumcision
01/2021
1Operative Surgical Procedures
07/2020
1Gastrectomy
07/2020
1Palliative Care (Palliative Therapy)
01/2020
1Therapeutics
01/2017
1Aftercare (After-Treatment)
10/2010